Latest uveitis Stories
Biohaven filed a pre-IND meeting request with the FDA regarding lead investigational agent BHV-0223, receives written response in lieu of an in-person meeting TORONTO, Dec.
TORONTO, Dec. 16, 2014 /PRNewswire/ - Portage Biotech Inc.
Largest retrospective study of its kind reveals that nearly 60 percent of patients with both uveitis and MS are diagnosed with each within a 5-year span CHICAGO, Oct.
DALLAS, September 30, 2014 /PRNewswire/ -- ReportsnReports.com adds Global Uveitis Market 2014-2018 [http://www.reportsnreports.com/reports/288388-global-uveitis-market-2014-2018.html
TORONTO, Sept. 23, 2014 /PRNewswire/ - Portage Biotech Inc.
DIEPENBEEK, Belgium, September 4, 2014 /PRNewswire/ -- Scientists discover how to 'switch off' autoimmune diseases Apitope, the drug discovery
Global Uveitis Market 2014-2018, a new research report available at ReportsnReports.com. Dallas, Texas (PRWEB) June 20, 2014 Currently, the current competition
NORTH CHICAGO, Ill., May 20, 2014 /PRNewswire/ -- AbbVie (NYSE:ABBV) announced today that the U.S.
- A trick or prank.